Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.66, No.4, p.524-531, 2019 |
||
Title: Glioma cell proliferation is inhibited by miR-342-3p, miR-377/E2F1 signaling pathway | ||
Author: H. Ying, C. Chi | ||
Abstract: In recent years, microRNAs (miRNAs) have been reported to be critical regulators to influence tumor genesis or its further progression by directly targeting downstream tumor related genes in glioma. However, there are still many underlying mechanisms related to miRNAs signaling pathway that remain to be uncovered. In the present study, we found that miR-342-3p and miR-377 inhibited the glioma cell line proliferation and arrested the cell cycle at G1 phase. Inhibition of miR-342-3p and miR-377 function promoted the cell proliferation. miR-342-3p and miR-377 target the E2F1 3’UTR to repress its expression on both mRNA and protein level. Downregulation of E2F1 inhibited the cell proliferation and arrested the cell cycle. Overexpression of E2F1 blocked the proliferation repression caused by miR-342-3p or miR-377 in glioma cells. This study showed the function of miR-342-3p, miR-377/E2F1 axis in regulating glioma cells proliferation and provided the potential therapeutic target. |
||
Keywords: glioma cell, proliferation, cell cycle, miRNAs, E2F1 | ||
Published online: 29-Jul-2019 | ||
Year: 2019, Volume: 66, Issue: 4 | Page From: 524, Page To: 531 | |
doi:10.4149/neo_2018_180805N574 |
||
|
download file |
|